Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 234 results for "Multiple Myeloma (MM)".

Thumbnail for Redefining the Horizon: A Deep Survival Mixture Meta-Analysis Quantifying the Statistical Cure Fraction of Cellular Therapies in Relapsed Multiple Myeloma

MM - 1520

Redefining the Horizon: A Deep Survival Mixture Meta-Analysis Quantifying the Statistical Cure Fraction of Cellular Therapies in Relapsed Multiple Myeloma

Haroon Alamy

Poster Presenter: Haroon Alamy

Thumbnail for Isolating the Anti-CD38 Component Effect in Newly Diagnosed Multiple Myeloma: A Component-Based Network Meta-Analysis of Phase 3 Randomized Trials

MM - 1523

Isolating the Anti-CD38 Component Effect in Newly Diagnosed Multiple Myeloma: A Component-Based Network Meta-Analysis of Phase 3 Randomized Trials

Raj Nandan Chennuri

Poster Presenter: Raj Nandan Chennuri

Previous 1...8 9 10 11 12 13 14...26 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Socioeconomic, Demographic, and Hospital-Level Predictors of In-Hospital Mortality in Multiple Myeloma: A 2022 National Inpatient Sample Analysis

MM - 1535

Socioeconomic, Demographic, and Hospital-Level Predictors of In-Hospital Mortality in Multiple Myeloma: A 2022 National Inpatient Sample Analysis

Kriti Yadav

Poster Presenter: Kriti Yadav

Thumbnail for Impact of Daratumumab-Based Regimens on Survival and Minimal Residual Disease Negativity in Multiple Myeloma: A Systematic Review and Meta-Analysis

MM - 1537

Impact of Daratumumab-Based Regimens on Survival and Minimal Residual Disease Negativity in Multiple Myeloma: A Systematic Review and Meta-Analysis

Anubhuti Sharma

Poster Presenter: Anubhuti Sharma

$Thumbnail for Cardiovascular Adverse Event Reporting Patterns With BCMA-Directed CAR-T and BCMA/GPRC5D Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A FAERS Disproportionality Analysis$

MM - 1542

Cardiovascular Adverse Event Reporting Patterns With BCMA-Directed CAR-T and BCMA/GPRC5D Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A FAERS Disproportionality Analysis

B?sranur Yilmaz

Poster Presenter: B?sranur Yilmaz

$Thumbnail for Efficacy and Safety Outcomes of Teclistamab in Relapsed/Refractory Multiple Myeloma: A Systematic Review$

MM - 1547

Efficacy and Safety Outcomes of Teclistamab in Relapsed/Refractory Multiple Myeloma: A Systematic Review

Maha Hameed

Poster Presenter: Maha Hameed

Thumbnail for 30-Day Non-Relapse Mortality In Multiple Myeloma Patients Treated with Bispecific T-cell Engagers: A Fear Analysis

MM - 1573

30-Day Non-Relapse Mortality In Multiple Myeloma Patients Treated with Bispecific T-cell Engagers: A Fear Analysis

Elias Tayar

Poster Presenter: Elias Tayar

$Thumbnail for True Extramedullary Versus Paraskeletal/Paramedullary Disease as Determinants of CAR-T Outcomes in Relapsed or Refractory Multiple Myeloma$

MM - 1579

True Extramedullary Versus Paraskeletal/Paramedullary Disease as Determinants of CAR-T Outcomes in Relapsed or Refractory Multiple Myeloma

Sri Pranita Cherukuri

Poster Presenter: Sri Pranita Cherukuri

Thumbnail for The Calculus of Relapse: A Neural Ordinary Differential Equation Model of Continuous Disease Acceleration Following CAR-T vs Bispecific Therapy in Multiple Myeloma

MM - 1585

The Calculus of Relapse: A Neural Ordinary Differential Equation Model of Continuous Disease Acceleration Following CAR-T vs Bispecific Therapy in Multiple Myeloma

Iman Khan

Poster Presenter: Iman Khan

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors